Advancing Pharmacoequity in Atrial Fibrillation-The Case for Direct Oral Anticoagulants

JAMA Netw Open. 2024 May 1;7(5):e249403. doi: 10.1001/jamanetworkopen.2024.9403.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Anticoagulants* / administration & dosage
  • Anticoagulants* / therapeutic use
  • Atrial Fibrillation* / drug therapy
  • Factor Xa Inhibitors / therapeutic use
  • Humans
  • Stroke / prevention & control

Substances

  • Anticoagulants
  • Factor Xa Inhibitors